×

Warning message

DIAL was requested successfully but there were no results for this search.

Publications

Bruxelles Woluwe

Selected publications

- Véronique Préat -

  • Bastiancich C, Bianco J, Vanvarenberg K, Ucakar B, Joudiou N, Gallez B, Bastiat G, Lagarce F, Préat V, Danhier F. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection. J Control Release. (2017) 264:4554
  • Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, Danhier F, Préat V. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIOloaded nanoparticles for tumor imaging and therapy. J Control Release. (2014) 194:8291.
  • Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. (2012) 161(2):505-22.
  • Danhier F., Feron O., Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anticancer drug delivery. J Control Release (2010), 148: 135-146.
  • Garinot M., Fievez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L., Theate I., Freichels H., Jerôme C., Marchand Brynaert J., Schneider Y.J., Préat V. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release (2007), 120: 195-204.

- Rita Vanbever-

  • Patil H.P., Freches D., Karmani L., Duncan G., Ucakar B., Suk J.S., Hanes J., Gallez B., Vanbever R. Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation J. Control. Release (2018) 272: 62-71.
  • Luo T., Loira-Pastoriza C., Patil H.P., Ucakar B., Muccioli G.G., Bosquillon C., Vanbever R. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma. J. Control. Release (2016) 239: 62-71.
  • Koussoroplis S.J., Paulissen G., Tyteca D., Goldansaz H., Todoroff J., Barilly C., Uyttenhove C., Van Snick J., Cataldo D., Vanbever R. PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract. J. Control Release (2014), 187: 91-100.
  • Loira-Pastoriza C., Todoroff J., Vanbever R. Delivery strategies for sustained drug release in the lungs (invited review). Adv. Drug Deliv. Rev. (2014), 75: 81-91.
  • Todoroff J., Lemaire M., Fillee C., Renauld J.-Ch., Huygen K., Vanbever R. Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice. Plos One (2013). 8 (5): 1-12.

- Gaëtane Leloup - Julian Leprince -

  • Randolph L. D., Palin W. M., Leprince, J. G. Dental Composite Materials for Direct Restorations, Editors: Miletic, Vesna (Ed.), Springer 2017 Chapter 2 : Composition of Dental ResinBased Composites for Direct Restorations Chapter 6 : Developing a More Appropriate Classification System for Modern ResinBased Composite Technologies
  • Leprince, J. G., Leloup G., Hardy C. M. F.The guidebook to molar endodontics, Editors: Peters, Ove A. (Ed.), Springer 2017 Chapter 7 : Considerations for the Restoration of Endodontically Treated Molars
  • Randolph L. D., Palin W. M., Bebelman S., Devaux J., Gallez B., Leloup G., Leprince, J. G. Photopolymerization of highly filled dimethacrylate-based composites using Type I or Type II photoinitiators and varying co-monomer ratios Dent Mater. 2016 Feb;32(2):136-48.
  • Randolph LD, Palin WM, Leloup G, Leprince JG. Filler characteristics of modern dental resin composites and their influence on physico-mechanical properties.Dent Mater. 2016 Dec;32(12):1586-1599.
  • Vanacker J., Viswanath A., De Berdt P., Everard A., Cani P. D., Bouzin C., Feron, O., Diogenes A., Leprince J. G., des Rieux A. Hypoxia Modulates the Differentiation Potential of Stem Cells of the Apical Papilla. Journal of Endodontics (2014), 40: 14101418.
  • Leprince J. G., Palin W. M., Hadis M. A., Devaux J., Leloup, G. Progress in dimethacrylate-based dental composite technology and curing efficiency. Dent Mater (2013), 29: 139-156.

- Anne des Rieux -

  • Beloqui A, Brayden DJ, Artursson P, Préat V, des Rieux A. A human intestinal M-celllike model for investigating particle, antigen and microorganism translocation. Nat Protoc.( 2017)12:1387-1399.
  • Carradori D, Eyer J, Saulnier P, Préat V, des Rieux A. The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation. Biomaterials. (2017) 123:77-91.
  • Viswanath A, Vanacker J, Germain L, Leprince JG, Diogenes A, Shakesheff KM, White LJ, des Rieux A. Extracellular matrixderived hydrogels for dental stem cell delivery. J Biomed Mater Res A. (2017) 105:319-328.
  • De Berdt P., Vanacker J., Ucakar B., Elens L., Diogenes A., Leprince J.G., Deumens R., des Rieux A.  Dental Apical Papilla as Therapy for Spinal Cord Injury. J Dent Res. (2015), 94(11):1575-1581.
  • Ansorena E., De Berdt P., Ucakar B., Simon-Yarza T., Jacobs D., Schakman O., Jankovski A., Deumens R., Blanco-Prieto M.J., Préat V., des Rieux A. Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury. Int J Pharm (2013), 455: 148-58.

- Ana Beloqui -

  • Shrestha N., Bouttefeux O., Vanvarenberg K., Lunquist P., Cunarro J., Tovar S., Khodus G., Andersson E., Keita Å.V., González Dieguez C., Artursson P., Préat V., Beloqui A. The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers. Nanoscale (2018) 10:603-613
  • Xu Y., Carradori D., Alhouayek M., Muccioli G. G., Cani P. D., Préat V., Beloqui A.  Size effect on lipid nanocapsule-mediated GLP-1 secretion from enteroendocrine L cells. Mol. Pharm. (2018) 15:108-115.
  • Beloqui A., des Rieux A., Préat V. Mechanisms of transport of polymeric and lepidic nanoparticles across the intestinal barrier. Adv. Drug Deliv. Rev. (2016) 106: 242-255.
  • Beloqui A., Coco R., Memvanga P.B., Ucakar B., des Rieux A., Préat V. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease, Int. J. Pharm. (2014) 473:203-212.
  • Beloqui A., Solinís M.A., Gascón A.R., del Pozo-Rodríguez A., des Rieux A., Préat V . Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier, J. Control. Release (2013) 166:115-123.